Natera (NTRA)
413.38
+7.46 (1.84%)
Upcoming Events
Latest Headlines
Form 144 Natera, Inc. Filed by: Sheena Jonathan
October 21, 2026 1:09 PM - SEC Filing
Form 4 Natera, Inc. For: Oct 16 Filed by: Sheena Jonathan
October 20, 2026 9:35 PM - SEC Filing
Natera (NTRA) PT Raised to $500 at Canaccord
October 19, 2026 7:51 AM - StreetInsider
ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
October 18, 2026 6:10 PM - BizWire
Form 4 Natera, Inc. For: Oct 15 Filed by: Rabinowitz Matthew
October 16, 2026 9:35 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
October 15, 2026 4:18 PM - SEC Filing
Natera’s Signatera™ MRD Test Named to TIME’s List of the Best Inventions of 2026
October 15, 2026 12:46 PM - BizWire
Natera (NTRA) PT Raised to $480 at TD Cowen
October 13, 2026 9:32 AM - StreetInsider
Natera (NTRA) PT Raised to $435 at Morgan Stanley
October 13, 2026 8:24 AM - StreetInsider
Natera and TransCode team up on colorectal cancer MRD trial
October 13, 2026 7:30 AM - StreetInsider
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
October 13, 2026 7:30 AM - BizWire
Form 4 Natera, Inc. For: Oct 07 Filed by: Rabinowitz Matthew
October 9, 2026 9:25 PM - SEC Filing
FDA grants breakthrough device designation to Natera's cancer detection test
October 9, 2026 8:01 AM - StreetInsider
FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
October 9, 2026 8:00 AM - BizWire
Natera (NTRA) PT Raised to $458 at Baird
October 8, 2026 7:23 AM - StreetInsider
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
October 7, 2026 8:00 AM - BizWire
Natera (NTRA) PT Raised to $475 at Barclays
October 7, 2026 3:51 AM - StreetInsider
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
October 6, 2026 8:00 AM - BizWire
Citi raises Natera price target to $480, keeps Buy rating
October 5, 2026 4:05 PM - StreetInsider
AFT and Natera launch phase III breast cancer MRD-guided therapy trial
October 5, 2026 8:04 AM - StreetInsider
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Gu
October 5, 2026 8:00 AM - BizWire
Form 4 Natera, Inc. For: Oct 01 Filed by: Chapman Steven Leonard
October 2, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Oct 01 Filed by: Moshkevich Solomon
October 2, 2026 9:35 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
October 1, 2026 4:25 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
October 1, 2026 4:04 PM - SEC Filing
Natera (NTRA) PT Raised to $475 at Guggenheim
October 1, 2026 8:48 AM - StreetInsider
Form 4 Natera, Inc. For: Sep 23 Filed by: Sheena Jonathan
September 25, 2026 9:35 PM - SEC Filing
Natera (NTRA) PT Raised to $460 at RBC Capital on 'Strong Setup'
September 25, 2026 8:35 AM - StreetInsider
Form 144 Natera, Inc. Filed by: Sheena Jonathan
September 23, 2026 10:58 AM - SEC Filing
Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
September 22, 2026 8:00 AM - BizWire
Form 4 Natera, Inc. For: Sep 16 Filed by: Moshkevich Solomon
September 18, 2026 9:35 PM - SEC Filing
Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM
September 18, 2026 6:00 AM - BizWire
Form 4 Natera, Inc. For: Sep 15 Filed by: Sheena Jonathan
September 17, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Sep 14 Filed by: Rabinowitz Matthew
September 16, 2026 9:35 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
September 15, 2026 4:54 PM - SEC Filing
Form 4 Natera, Inc. For: Sep 11 Filed by: Rabinowitz Matthew
September 11, 2026 9:35 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
September 11, 2026 4:29 PM - SEC Filing
UBS Assumes Natera (NTRA) at Buy
September 9, 2026 6:08 AM - StreetInsider
Rothschild Redburn Starts Natera (NTRA) at Buy
September 8, 2026 3:26 AM - StreetInsider
Natera (NTRA) PT Raised to $376 at Baird
September 3, 2026 7:06 AM - StreetInsider
Form 4 Natera, Inc. For: Aug 06 Filed by: Fesko John
August 28, 2026 9:35 PM - SEC Filing
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
August 28, 2026 11:03 AM - BizWire
Natera partners with Angiex to monitor cancer drug trial with ctDNA test
August 27, 2026 6:01 AM - StreetInsider
Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
August 27, 2026 6:00 AM - BizWire
Form 4 Natera, Inc. For: Aug 10 Filed by: Sheena Jonathan
August 14, 2026 9:35 PM - SEC Filing
Form SCHEDULE 13G/A Natera, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
August 14, 2026 10:40 AM - SEC Filing
Natera (NTRA) PT Raised to $363.50 at Piper Sandler
August 12, 2026 9:18 AM - StreetInsider
Natera (NTRA) PT Raised to $350 at Stephens
August 12, 2026 9:09 AM - StreetInsider
Natera (NTRA) PT Raised to $360 at Guggenheim
August 12, 2026 6:53 AM - StreetInsider
Natera to supply MRD testing for Kupando skin cancer trial
August 12, 2026 6:01 AM - StreetInsider
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
August 12, 2026 6:00 AM - BizWire
Natera (NTRA) PT Raised to $355 at Morgan Stanley
August 10, 2026 8:37 AM - StreetInsider
Natera (NTRA) PT Raised to $340 at Barclays
August 10, 2026 4:22 AM - StreetInsider
Form 4 Natera, Inc. For: Aug 07 Filed by: Sheena Jonathan
August 7, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 07 Filed by: Rabinowitz Matthew
August 7, 2026 9:35 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
August 7, 2026 5:43 PM - SEC Filing
Form S-8 Natera, Inc.
August 7, 2026 5:05 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Sheena Jonathan
August 7, 2026 10:41 AM - SEC Filing
Natera (NTRA) PT Raised to $385 at Bernstein SocGen Group
August 7, 2026 9:11 AM - StreetInsider
Natera (NTRA) PT Raised to $360 at JPMorgan
August 7, 2026 9:09 AM - StreetInsider
Natera (NTRA) PT Raised to $340 at TD Cowen
August 7, 2026 8:51 AM - StreetInsider
Natera (NTRA) PT Raised to $284 at Wells Fargo
August 7, 2026 8:24 AM - StreetInsider
Natera (NTRA) PT Raised to $350 at RBC Capital
August 7, 2026 7:29 AM - StreetInsider
Form 10-Q Natera, Inc. For: Jun 30
August 7, 2026 6:22 AM - SEC Filing
Natera (NTRA) Tops Q2 EPS by 2c ; Offers Guidance
August 7, 2026 1:26 AM - StreetInsider
Form 8-K Natera, Inc. For: Aug 06
August 6, 2026 4:07 PM - SEC Filing
Natera Reports Second Quarter 2026 Financial Results
August 6, 2026 4:05 PM - BizWire
Form 4 Natera, Inc. For: Aug 03 Filed by: Chapman Steven Leonard
August 5, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 03 Filed by: Fesko John
August 5, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 03 Filed by: Brophy Michael Burkes
August 5, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 03 Filed by: Moshkevich Solomon
August 5, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 03 Filed by: RABINOWITZ DANIEL
August 5, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 03 Filed by: Rabinowitz Matthew
August 5, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Aug 03 Filed by: Sheena Jonathan
August 5, 2026 9:35 PM - SEC Filing
Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
August 5, 2026 6:00 AM - BizWire
Form 144 Natera, Inc. Filed by: Brophy Michael Burkes
August 4, 2026 4:36 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Sheena Jonathan
August 3, 2026 4:23 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
August 3, 2026 4:23 PM - SEC Filing
Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL
August 3, 2026 4:22 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
August 3, 2026 4:22 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Fesko John
August 3, 2026 4:21 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
August 3, 2026 4:21 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Brophy Michael Burkes
August 3, 2026 4:21 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
August 3, 2026 4:19 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
August 3, 2026 4:09 PM - SEC Filing
Citi Assumes Natera (NTRA) at Buy
July 30, 2026 10:03 AM - StreetInsider
Natera to Report its Second Quarter Results on August 6, 2026
July 30, 2026 8:00 AM - BizWire
Form 4 Natera, Inc. For: Jul 27 Filed by: RABINOWITZ DANIEL
July 29, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Jul 27 Filed by: Sheena Jonathan
July 29, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Jul 27 Filed by: Rabinowitz Matthew
July 29, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Jul 27 Filed by: Moshkevich Solomon
July 29, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Jul 27 Filed by: Fesko John
July 29, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Jul 27 Filed by: Chapman Steven Leonard
July 29, 2026 9:35 PM - SEC Filing
Form 4 Natera, Inc. For: Jul 27 Filed by: Brophy Michael Burkes
July 29, 2026 9:35 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Brophy Michael Burkes
July 29, 2026 4:21 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Brophy Michael Burkes
July 28, 2026 4:40 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Sheena Jonathan
July 28, 2026 4:09 PM - SEC Filing
Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL
July 28, 2026 4:09 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Fesko John
July 28, 2026 4:08 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
July 28, 2026 4:08 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
July 28, 2026 4:08 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Brophy Michael Burkes
July 28, 2026 4:08 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Sheena Jonathan
July 27, 2026 3:37 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Rabinowitz Matthew
July 27, 2026 3:36 PM - SEC Filing
Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL
July 27, 2026 3:36 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Fesko John
July 27, 2026 3:36 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
July 27, 2026 3:36 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Chapman Steven Leonard
July 27, 2026 3:36 PM - SEC Filing
Form 144 Natera, Inc. Filed by: Brophy Michael Burkes
July 27, 2026 3:36 PM - SEC Filing
TD Cowen reports short interest changes in life science stocks
July 27, 2026 12:15 PM - StreetInsider
Full Article List